Candesant Biomedical Is A Clinical Stage Medical Device Company Dedicated To Developing Solutions For Managing Excessive Sweatingor Hyperhidrosisthe Company Focuses On Improving The Lives Of Individuals Affected By This Condition By Offering Innovative Therapiesparticularly For Axillaryunderarmsweatingwith Plans To Expand To Other Areas Such As Palmarplantarand Facial Hyperhidrosis The Company Has Created A Proprietary Technology Called Targeted Alkali Thermolysistat Which Is Used In Its Productthe Brellaasweatcontrol Patchthis Bi Layer Patch Provides Sweat Control In Just Three Minutesmaking It A Convenient Option For Those Seeking Relief From Excessive Sweatingcandesant Biomedical Aims To Provide In Office Treatments As Part Of Its Service Offeringsstarting With Axillary Sweating With A Recent $35 Million In Series B Financingcandesant Biomedical Is Advancing The Commercialization Of Its Brella Patchthe First Fda Cleared 3 Minute Sweat Control Patchthe Company Is Committed To Addressing The Needs Of The Approximately 84 Million People In The U Swho Experience Hyperhidrosis
